BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24316739)

  • 1. Protonation drives the conformational switch in the multidrug transporter LmrP.
    Masureel M; Martens C; Stein RA; Mishra S; Ruysschaert JM; Mchaourab HS; Govaerts C
    Nat Chem Biol; 2014 Feb; 10(2):149-55. PubMed ID: 24316739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic residues R260 and K357 affect the conformational dynamics of the major facilitator superfamily multidrug transporter LmrP.
    Wang W; van Veen HW
    PLoS One; 2012; 7(6):e38715. PubMed ID: 22761697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two proton translocation pathways in a secondary active multidrug transporter.
    Bapna A; Federici L; Venter H; Velamakanni S; Luisi B; Fan TP; van Veen HW
    J Mol Microbiol Biotechnol; 2007; 12(3-4):197-209. PubMed ID: 17587868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hoechst 33342 Is a Hidden "Janus" amongst Substrates for the Multidrug Efflux Pump LmrP.
    Neuberger A; van Veen HW
    PLoS One; 2015; 10(11):e0141991. PubMed ID: 26540112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LmrP from Lactoccoccus lactis: a tractable model to understand secondary multidrug transport in MFS.
    Roth A; Govaerts C
    Res Microbiol; 2018; 169(7-8):468-477. PubMed ID: 30145366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An embedded lipid in the multidrug transporter LmrP suggests a mechanism for polyspecificity.
    Debruycker V; Hutchin A; Masureel M; Ficici E; Martens C; Legrand P; Stein RA; Mchaourab HS; Faraldo-Gómez JD; Remaut H; Govaerts C
    Nat Struct Mol Biol; 2020 Sep; 27(9):829-835. PubMed ID: 32719456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relocation of active site carboxylates in major facilitator superfamily multidrug transporter LmrP reveals plasticity in proton interactions.
    Nair AV; Singh H; Raturi S; Neuberger A; Tong Z; Ding N; Agboh K; van Veen HW
    Sci Rep; 2016 Dec; 6():38052. PubMed ID: 27917857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protonation-dependent conformational dynamics of the multidrug transporter EmrE.
    Dastvan R; Fischer AW; Mishra S; Meiler J; Mchaourab HS
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1220-5. PubMed ID: 26787875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitated drug influx by an energy-uncoupled secondary multidrug transporter.
    Mazurkiewicz P; Poelarends GJ; Driessen AJ; Konings WN
    J Biol Chem; 2004 Jan; 279(1):103-8. PubMed ID: 14561761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexities of a protonatable substrate in measurements of Hoechst 33342 transport by multidrug transporter LmrP.
    Swain BM; Guo D; Singh H; Rawlins PB; McAlister M; van Veen HW
    Sci Rep; 2020 Nov; 10(1):20026. PubMed ID: 33208856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Multidrug Transporter MdfA Deviates from the Canonical Model of Alternating Access of MFS Transporters.
    Yardeni EH; Mishra S; Stein RA; Bibi E; Mchaourab HS
    J Mol Biol; 2020 Sep; 432(20):5665-5680. PubMed ID: 32860775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton motive force mediates a reorientation of the cytosolic domains of the multidrug transporter LmrP.
    Gbaguidi B; Mazurkiewicz P; Konings WN; Driessen AJ; Ruysschaert JM; Vigano C
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2646-57. PubMed ID: 15526169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flexible cation binding site in the multidrug major facilitator superfamily transporter LmrP is associated with variable proton coupling.
    Schaedler TA; van Veen HW
    FASEB J; 2010 Oct; 24(10):3653-61. PubMed ID: 20472749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids modulate the conformational dynamics of a secondary multidrug transporter.
    Martens C; Stein RA; Masureel M; Roth A; Mishra S; Dawaliby R; Konijnenberg A; Sobott F; Govaerts C; Mchaourab HS
    Nat Struct Mol Biol; 2016 Aug; 23(8):744-51. PubMed ID: 27399258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AlphaFold2 predicts the inward-facing conformation of the multidrug transporter LmrP.
    Del Alamo D; Govaerts C; Mchaourab HS
    Proteins; 2021 Sep; 89(9):1226-1228. PubMed ID: 33973689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium and proton coupling in the conformational cycle of a MATE antiporter from
    Claxton DP; Jagessar KL; Steed PR; Stein RA; Mchaourab HS
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6182-E6190. PubMed ID: 29915043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug transporters and antibiotic resistance in Lactococcus lactis.
    Poelarends GJ; Mazurkiewicz P; Konings WN
    Biochim Biophys Acta; 2002 Sep; 1555(1-3):1-7. PubMed ID: 12206883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetics of wild-type and mutant multidrug resistance secondary transporter LmrP of Lactococcus lactis.
    Mazurkiewicz P; Driessen AJ; Konings WN
    Biochim Biophys Acta; 2004 Oct; 1658(3):252-61. PubMed ID: 15450963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between phosphatidylethanolamine headgroup and LmrP, a multidrug transporter: a conserved mechanism for proton gradient sensing?
    Hakizimana P; Masureel M; Gbaguidi B; Ruysschaert JM; Govaerts C
    J Biol Chem; 2008 Apr; 283(14):9369-76. PubMed ID: 18234676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ins and outs of major facilitator superfamily antiporters.
    Law CJ; Maloney PC; Wang DN
    Annu Rev Microbiol; 2008; 62():289-305. PubMed ID: 18537473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.